Evolus Inc (FRA:EVL)
€ 15.2 0.4 (2.7%) Market Cap: 952.15 Mil Enterprise Value: 982.57 Mil PE Ratio: 0 PB Ratio: 53.62 GF Score: 52/100

Evolus Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 10, 2020 / 05:20PM GMT
Release Date Price: €3.02 (-7.92%)
Operator

Please be advised that today's conference is being recorded. Thank you.

Jacob Hughes
Wells Fargo Securities - Analyst

Perfect. Hi, everyone. I am Jacob Hughes, specialty pharmaceutical analyst at Wells Fargo. I'm very pleased to introduce our next fireside chat with the bolus Evolus. From the Company we have President and CEO, David Moatazedi; Chief Financial Officer and EVP of Corporate Development, Lauren Silvernail; and VP of Finance, IR and Treasury, Ashwin Agarwal. (Operator Instructions). David, maybe I'll kick it over to you for a brief overview and catch up on the state of the business and then we can jump into Q&A.

David Moatazedi
Evolus, Inc. - President & CEO

Sounds great. Jacob, thank you and Wells Fargo for having Evolus on this fireside chat. It's a pleasure to be here with you all. I'll start by just giving a background on the Company for those of you that are not familiar with Evolus.

It's a company that was formed seven years ago, focused and dedicated to the space of medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot